HomeCTMX • NASDAQ
add
CytomX Therapeutics Inc
Previous close
$4.08
Day range
$3.92 - $4.09
Year range
$0.40 - $4.62
Market cap
669.27M USD
Avg Volume
3.22M
P/E ratio
9.81
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 5.96M | -82.16% |
Operating expense | 21.73M | -25.89% |
Net income | -14.23M | -348.06% |
Net profit margin | -238.62 | -1,490.56% |
Earnings per share | -0.09 | -228.57% |
EBITDA | -15.63M | -444.36% |
Effective tax rate | -0.41% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 143.63M | 22.14% |
Total assets | 158.25M | 13.87% |
Total liabilities | 50.86M | -68.69% |
Total equity | 107.39M | — |
Shares outstanding | 169.44M | — |
Price to book | 6.28 | — |
Return on assets | -23.65% | — |
Return on capital | -32.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -14.23M | -348.06% |
Cash from operations | -15.55M | 24.99% |
Cash from investing | 439.00K | -97.58% |
Cash from financing | 253.00K | — |
Net change in cash | -14.86M | -480.09% |
Free cash flow | -5.50M | 71.79% |
About
Founded
2008
Headquarters
Website
Employees
120
